Loading clinical trials...
Loading clinical trials...
The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development
Conditions
Interventions
Infant Formula: enriched level of myelin-relevant nutrients
Infant formula: standard level of myelin-relevant nutrients
Locations
2
United States
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Start Date
March 13, 2017
Primary Completion Date
February 28, 2021
Completion Date
February 28, 2022
Last Updated
July 21, 2022
NCT07310264
NCT06716502
NCT06290258
NCT00090662
NCT07483606
NCT07310901
Lead Sponsor
Société des Produits Nestlé (SPN)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions